TCI GENE Inc. (TPEX:6879)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
35.10
-0.90 (-2.50%)
Mar 24, 2026, 1:41 PM CST

TCI GENE Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
273.61347.54333.86424.02432.22
Revenue Growth (YoY)
-21.27%4.10%-21.27%-1.90%124.01%
Cost of Revenue
121.02143.47159.24180.66192.79
Gross Profit
152.59204.07174.62243.36239.43
Selling, General & Admin
99.83114.17122.9889.9366.4
Research & Development
33.6834.1445.6262.3359.46
Operating Expenses
131.65151.57168.69152.8126.18
Operating Income
20.9352.55.9390.56113.25
Interest Expense
-1.4-0.5-1.18-0.85-0.84
Interest & Investment Income
3.0637.819.673.640.23
Earnings From Equity Investments
-8.12-9.35-5.86-3.45-
Currency Exchange Gain (Loss)
-0.05-0.07-0.69-0.24
Other Non Operating Income (Expenses)
24.490.170.220.685.96
EBT Excluding Unusual Items
38.9780.688.7189.89118.36
Gain (Loss) on Sale of Investments
--20.15---1.94
Gain (Loss) on Sale of Assets
-7.03-0.240.01
Other Unusual Items
--0.06--
Pretax Income
38.9767.568.7890.13116.44
Income Tax Expense
-0.1111.03-8.1815.7924.29
Earnings From Continuing Operations
39.0856.5316.9574.3492.14
Minority Interest in Earnings
1.49-0.21-5.28-2.190.31
Net Income
40.5756.3111.6772.1592.45
Net Income to Common
40.5756.3111.6772.1592.45
Net Income Growth
-27.96%382.40%-83.82%-21.96%158.63%
Shares Outstanding (Basic)
2726262419
Shares Outstanding (Diluted)
2727262520
Shares Change (YoY)
0.60%0.18%7.71%24.22%5.74%
EPS (Basic)
1.532.130.442.954.84
EPS (Diluted)
1.522.120.442.934.67
EPS Growth
-28.30%381.82%-84.98%-37.26%144.50%
Free Cash Flow
150.9154.415.4696.496.39
Free Cash Flow Per Share
5.662.050.583.924.87
Dividend Per Share
-2.0001.0002.0002.028
Dividend Growth
-100.00%-50.00%-1.36%-
Gross Margin
55.77%58.72%52.30%57.39%55.40%
Operating Margin
7.65%15.11%1.78%21.36%26.20%
Profit Margin
14.83%16.20%3.50%17.01%21.39%
Free Cash Flow Margin
55.16%15.65%4.63%22.73%22.30%
EBITDA
32.9159.7915.11112.07145.86
EBITDA Margin
12.03%17.20%4.53%26.43%33.75%
D&A For EBITDA
11.987.299.1821.5132.61
EBIT
20.9352.55.9390.56113.25
EBIT Margin
7.65%15.11%1.78%21.36%26.20%
Effective Tax Rate
-16.33%-17.52%20.86%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.